During the recent session, Pfizer Inc. (NYSE:PFE)’s traded shares were 5.5 million, with the beta value of the company hitting 0.65. At the last check today, the stock’s price was $29.00, reflecting an intraday loss of -1.14% or -$0.34. The 52-week high for the PFE share is $33.92, that puts it down -16.97 from that peak though still a striking 13.1% gain since the share price plummeted to a 52-week low of $25.20. The company’s market capitalization is $164.36B, and the average intraday trading volume over the past 10 days was 32.17 million shares, and the average trade volume was 32.17 million shares over the past three months.
Pfizer Inc. (PFE) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.20. PFE has a Sell rating from 1 analyst(s) out of 16 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.59.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc. (NYSE:PFE) trade information
Pfizer Inc. (PFE) registered a -1.14% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.14% in intraday trading to $29.00, hitting a weekly high. The stock’s 5-day price performance is 1.49%, and it has moved by -0.53% in 30 days. Based on these gigs, the overall price performance for the year is -12.40%. The short interest in Pfizer Inc. (NYSE:PFE) is 67.62 million shares and it means that shorts have 2.23 day(s) to cover.
The consensus price target of analysts on Wall Street is $46, which implies an increase of 36.96% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20 and $70 respectively. As a result, PFE is trading at a discount of -141.38% off the target high and 31.03% off the low.
Pfizer Inc. (PFE) estimates and forecasts
Statistics show that Pfizer Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Pfizer Inc. (PFE) shares have gone up 12.16% during the last six months, with a year-to-date growth rate more than the industry average at 44.57% against 6.30. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 447.10% this quarter and then jump 580.00% in the quarter after that. In the rating firms’ projections, revenue will increase 4.40% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 14.76B as predicted by 14 analyst(s). Meanwhile, a consensus of 12 analyst(s) estimates revenue growth to 18.09B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 13.23B and 14.25B respectively. In this case, analysts expect current quarter sales to grow by 11.60% and then jump by 27.00% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -27.43%. While earnings are projected to return 44.45% in 2024, the next five years will return 10.00% per annum.
PFE Dividends
Pfizer Inc. is due to release its next quarterly earnings on 2024-Oct-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Pfizer Inc. is 1.67, with the dividend yield indicating at 5.76 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 4.2%.
Pfizer Inc. (NYSE:PFE)’s Major holders
Pfizer Inc. insiders own 0.05% of total outstanding shares while institutional holders control 67.52%, with the float percentage being 67.55%. VANGUARD GROUP INC is the largest shareholder of the company, while 3618.0 institutions own stock in it. As of 2024-06-30, the company held over 511.4 million shares (or 9.0402% of all shares), a total value of $14.31 billion in shares.
The next largest institutional holding, with 424.38 million shares, is of BLACKROCK INC.’s that is approximately 7.5018% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $11.87 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Pfizer Inc. (PFE) shares are Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 179.12 shares. This amounts to just over 3.16 percent of the company’s overall shares, with a $5.22 billion market value. The same data shows that the other fund manager holds slightly less at 145.44, or about 2.57% of the stock, which is worth about $4.24 billion.
